Compare Eli Lilly And Co (LLY) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs US Bancorp — how do they compare? Eli Lilly And Co trades at $1,215.28 (market cap $1.10T), while US Bancorp trades at $64.67 (market cap $100.01B). The key difference: Eli Lilly And Co is far larger — about 11× US Bancorp's market cap, and US Bancorp pays the higher dividend (3.24%). Which is the better fit depends on your goals.
| LLY | USB | |
|---|---|---|
Market Cap | $1.10T | $100.01B |
Sector | Health | Financials |
52-Week High | $1.24K | $64.47 |
52-Week Low | $639.43 | $45.28 |
Enterprise Value | $1.14T | — |
Dividend Yield | 0.56% | 3.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
